Trial Profile
Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin aspart; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 05 Nov 2010 New trial record.